Aflatoxin B1-induced mitotic recombination in L5178Y mouse lymphoma cells

Mutagenesis

Volumn 15, Issue 1, 2000, Pages 91-97

  Preisler, Verena ^a   Caspary, William J ^b   Hoppe, Florian ^a   Hagen, Rudolf ^a   Stopper, Helga ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CARCINOGEN; MUTAGENIC AGENT;

ANIMAL CELL; ARTICLE; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; GENETIC RECOMBINATION; IN SITU HYBRIDIZATION; LEUKEMIA L 5178 Y; LYMPHOMA CELL LINE; MAMMAL CELL; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ANIMALIA; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0033956999     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/15.1.91     Document Type: Article

References (48)

1. Aguilar, F., Hussain, S.P. and Cerutti, P. (1993) Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl Acad. Sci. USA, 90, 8586-8590.
2. Bailey, E.A., Iyer, R.S., Stone, M.P., Harris, T.M. and Essigmann, J.M. (1996) Mutational properties of the primary aflatoxin B1-DNA adduct. Proc. Natl Acad. Sci. USA, 93, 1535-1539.
3. Bauer Hofmann, R., Buchmann, A., Wright, A.S. and Schwarz, M. (1990) Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CF1 mouse. Carcinogenesis, 11, 1875-1877.
4. Blazak, W., Stewart, B., Galperin, I., Allen, K., Rudd, C., Mitchell, A. and Caspary, W. (1986) Chromosome analysis of trifluorothymidine-resistant L5178Y mouse lymphoma cell colonies. Environ. Mutagen., 8, 229-240.
5. Bressac, B., Kew, M., Wands, J. and Ozturk, M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa [see comments]. Nature, 350, 429-431.
6. Caspary, W.J., Stopper, H., Hozier, J., Liechty, M. and Davis, L. (1997) Mechanisms leading to the expression of recessive alleles: the use of polymorphic microsatellites and whole chromosome painting probes to analyze mouse tumors, mutants and micronuclei. In Mueller-Hermelink, H.K. (ed.), Risk and Progression Factors in Carcinogenesis. Springer-Verlag, Berlin, Vol. 143, pp. 161-182.
7. Cavenee, W.K., Dryja, T.P., Phillips, R.A., Benedict, W.F., Godbout, R., Gallie, B.L., Murphree, A.L., Strong, L.C. and White, R.L. (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature, 305, 779-784.
8. Choi, M.J., Lee, J.W. and Lee, B.M. (1996) Comparative assessment of DNA adduct formation, Salmonella mutagenicity and chromosome aberration assays as short-term tests for DNA damage. J. Toxicol. Environ. Health, 49, 271-284.
9. Clive, D., Flamm, W.G., Machesko, M.R. and Bernheim, N.J. (1972) Mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res., 16, 77-87.
10. Eaton, D.L. and Gallagher, E.P. (1994) Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 34, 135-172.
11. Garner, R.C., Dvorackova, I. and Tursi, F. (1988) Immunoassay procedures to detect exposure to aflatoxin B1 and benzo(a)pyrene in animals and man at the DNA level. Int. Arch. Occup Environ. Health, 60, 145-150.
12. Gerbes, A.L. and Caselmann, W.H. (1993) Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins. J. Hepatol., 19, 312-315.
13. Groopman, J.D., Zhu, J.Q., Donahue, P.R., Pikul, A., Zhang, L.S., Chen, J.S. and Wogan, G.N. (1992). Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res., 52, 45-52.
14. +/- 3.7.2C mouse-lymphoma cell line. Mutat. Res., 105, 451-456.
15. Hozier, J., Applegate, M. and Moore, M.M. (1992) In vitro mammalian mutagenesis as a model for genetic lesions in human cancer. Mutat. Res., 270, 201-209.
16. Hsieh, L.L., Hsu, S.W., Chen, D.S. and Santella, R.M. (1988) Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer Res., 48, 6328-6331.
17. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J. and Harris, C.C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas [see comments]. Nature, 350, 427-428.
18. IARC (1993) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Scientific Publications no. 56, IARC, Lyon, pp. 245-396.
19. Lee, H.S., Sarosi, I. and Vyas, G.N. (1989) Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology, 97, 1281-1287.
20. Li, C.Y., Yandell, D.W. and Little, J.B. (1992) Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro. Somat. Cell Mol. Genet., 18, 77-87.
21. Li, D., Cao, Y., He, L., Wang, N.J. and Gu, J.R. (1993) Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis, 14, 169-173.
22. -/- mutants. Mutat. Res., 286, 299-307.
23. Liechty, M., Scalzi, J., Davis, L., Spencer, D., Hozier, J. and Caspary, W. (1996a) Recombination and terminal deletions in L5178Y mouse cells. Environ. Mol. Mutagen., 27 (suppl. 27), 41.
24. Liechty, M.C., Crosby, H., Murthy, A., Davis, L.M., Caspary, W.J. and Hozier, J.C. (1996b) Identification of a polymorphic microsatellite within the tk gene in L5178Y mouse lymphoma cells. Mutat. Res., 371, 265-271.
25. Liechty, M., Scalzi, J., Sims, K., Crosby, H., Spencer, D., Davis, L., Caspary, W. and Hozier, J. (1998) Analysis of large and small colony L5178Y ti-l-mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: detection of recombination. Mutagenesis, 13, 461-474.
26. Müller, H. and Scott, R. (1992) Hereditary conditions in which the loss of heterozygosity may be important. Mutat. Res., 284, 15-24.
27. McMahon, G., Hanson, L., Lee, J.J. and Wogan, G.N. (1986) Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. Proc. Natl Acad Sci. USA, 83, 9418-9422.
28. Murakami, Y., Hayashi, K., Hirohashi, S. and Sekiya, T. (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51, 5520-5525.
29. Riley, J., Mandel, H.G., Sinha, S., Judah, D.J. and Neal, G.E. (1997) In vitro activation of the human Harvey-ras proto-oncogene by aflatoxin B1. Carcinogenesis, 18, 905-910.
30. Rudd, C., Daston, D. and Caspary, W. (1990) Spontaneous mutation rates in mammalian cells: effect of differential growth rates and phenotypic lag. Genetics, 126, 435-442.
31. Sargeant, K., O'Kelly, J., Carnaghan, R. and Allcroft, R. (1961) The assay of a toxic principle in certain groundnut meals. Vet. Rec., 73, 1219-1222.
32. +/- 3.7.2C mouse lymphoma cell line. Mutat. Res., 147, 243-253.
33. Scorsone, K.A., Zhou, Y.Z., Butel, J.S. and Slagle, B.L. (1992) p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res., 52, 1635-1638.
34. Sengstag, C. (1997) The molecular mechanism of aflatoxin B1-induced liver cancer: is mitotic recombination involved? Mol. Carcinog., 19, 147-152.
35. Sengstag, C. and Wurgler, F.E. (1994) DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes. Mol. Carcinog., 11, 227-235.
36. Sengstag, C., Weibel, B. and Fasullo, M. (1996) Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae. Cancer Res., 56, 5457-5465.
37. Sinha, S., Webber, C., Marshall, C.J., Knowles, M.A., Proctor, A., Barrass, N.C. and Neal, G.E. (1988) Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis. Proc. Natl Acad. Sci. USA, 85, 3673-3677.
38. Smith, L.E. and Grosovsky, A.J. (1993) Genetic instability on chromosome 16 in a human B lymphoblastoid cell line. Somat. Cell Mol. Genet., 19, 515-527.
39. Soman, N.R. and Wogan, G.N. (1993) Activation of the c-Ki-ras oncogene in aflatoxin B1-induced hepatocellular carcinoma and adenoma in the rat: detection by denaturing gradient gel electrophoresis. Proc. Natl Acad. Sci. USA, 90, 2045-2049.
40. Spencer, D.L. and Caspary, W.J. (1994) In situ and suspension protocols for mutation in L5178Y mouse cells: dose response and colony size distribution. Mutat. Res., 322, 291-300.
41. Spencer, D.L., Hines, K.C. and Caspary, W.J. (1994) An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells. Mutat. Res., 312, 85-98.
42. 2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res., 37, 172-181.
43. Wild, C.P., Hudson, G.J., Sabbioni, G., Chapot, B., Hall, A.J., Wogan, G.N., Whittle, H., Montesano, R. and Groopman, J.D. (1992) Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol. Biomarkers Prev., 1, 229-234.
44. Wogan, G. (1973) Aflatoxin carcinogenesis. In Busch, H. (ed.), Methods in Cancer Research. Academic Press, New York, NY, pp. 309-344.
45. 1 carcinogenesis in the rat. Cancer Res., 27, 2370-2376.
46. Xia, F., Amundson, S.A., Nickoloff, J.A. and Liber, H.L. (1994) Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation. Mol. Cell. Biol., 14, 5850-5857.
47. Zhang, Y.J., Chen, C.J., Lee, C.S., Haghighi, B., Yang, G.Y., Wang, L.W., Feitelson, M. and Santella, R. (1991) Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Carcinogenesis, 12, 2247-2252.
48. Zhu, Y., Stambrook, P.J. and Tischfield, J.A. (1993) Loss of heterozygosity: the most frequent cause of recessive phenotype expression at the heterozygous human adenine phosphoribosyltransferase locus. Mol. Carcinog., 8, 138-144.